Objective The current study examined the application of a screening tool to identify biopsychosocial risk factors and derive prognostic risk groups in children and adolescents with headache pain. Methods Youth (n ¼ 242, 8-17 years, 75.6% female) presenting for evaluation at a tertiary pediatric headache clinic completed the nine-item Pediatric Pain Screening Tool (PPST) as well as measures of functional disability, pain catastrophizing, fear of pain, anxiety, and depressive symptoms. In addition, 119 patients reported on functional disability at 2-month follow-up. Results The PPST demonstrated discriminant validity that ranged from fair to good for identifying significant disability and high emotional distress. Receiver operating characteristic curve analyses indicated that established cutoff scores were appropriate for the current sample, and thus participants were classified into low-risk (21%), medium-risk (31%), and high-risk (48%) groups. Only 1-6% of patients who met reference standard case status for disability and emotional distress were classified as low risk, whereas 64-90% of patients who met reference standard case status were classified as high risk, suggesting robust stratification. Conclusions The nine-item PPST may be a useful tool for efficiently identifying young patients with headache who are at risk of poor outcomes, and effectively classifying them into risk groups that could drive stratified treatment directly targeting patient needs.
Introduction
Headache is one of the most commonly reported pain complaints in childhood and adolescence (Perquin et al., 2000) . Epidemiological studies indicate that up to 69% of youth experience headache, with 6-31% reporting headaches that recur at least once per week (King et al., 2011) . Recurrent headaches are associated with poorer physical and psychosocial functioning in youth, including increased anxiety and depressive symptoms (Powers, Gilman, & Hershey, 2006) and school absenteeism (Newacheck & Taylor, 1992) . While for many young people their headaches eventually reduce and they achieve recovery (Wang, Fuh, & Lu, 2009 ), a significant proportion of youth experience headaches that persist even into adulthood (Brna, Dooley, Gordon, & Dewan, 2005) . Thus, there is a clear need to identify those young people at risk for adverse headache-related outcomes to better select and target treatment approaches. Brief screening tools that provide rapid risk classification in clinical care settings are well suited for this purpose; however, these tools have not yet been examined in a sample of youth with persistent headache.
Biopsychosocial models acknowledge that headache stems from a complex interaction between biological and psychosocial variables (Andrasik, Flor, & Turk, 2005; Nicholson, Houle, Rhudy, & Norton, 2007) . A recent study indicates equivalent efficacy of commonly used analgesics such as amitriptyline and topiramate compared with placebo in young people with chronic headache or migraine (Powers et al., 2017) . Relatedly, cognitive behavioral therapies (CBTs) have been shown to effectively reduce pain and disability at posttreatment and at longer-term follow-up in young people with chronic headache (Fisher et al., 2014) . Both the placebo response and biobehavioral approaches highlight the importance of top-down cognitive affective modulation of symptoms in pediatric headache, and indicate the inclusion of both biological and psychosocial variables in screening tools for this population.
The most commonly used pain-related screening tool to date is the Keele STarT Back Screening Tool (SBST), developed for adults with low back pain (LBP). The SBST has shown strong validity (Hill et al., 2008) and early promise in predicting disability outcomes, although findings are less promising for predicting pain symptomatology specifically . Importantly, early findings indicate that the SBST is also predictive of adult treatment response (Wideman et al., 2012) . Stratifying care based on identified risk has also shown promise; this approach is associated with incremental increases in quality of life years and reductions in health care costs compared with current best practice for adult LBP (Hill et al., 2011) . The SBST scores define low-, medium-, and high-risk levels. Classification of "high risk" is driven primarily by psychosocial variables, suggesting that tools similar to the SBST could be useful in other conditions such as headache, without necessarily needing to develop a headache-specific screening tool.
The SBST was recently adapted for youth with pain complaints to form the Pediatric Pain Screening Tool (PPST) (Simons et al., 2015) . The PPST is similar to the SBST in that it is a nine-item self-report questionnaire with most items asking for individuals to respond "yes" or "no." There are two subscales: physical (four items) and psychosocial (five items). Items on the PPST physical subscale were modified to be more general in nature ("My pain is in more than one body part") rather than back-pain specific ("My back pain has spread down my legs"), and the language was modified to be developmentally appropriate for youth. The PPST was validated in a sample of youth with mixed pain complaints, where the most common diagnosis was musculoskeletal pain. Using the PPST, Simons and colleagues derived cutoff scores for grouping patients into low-risk (few negative prognostic indicators), mediumrisk (moderately unfavorable prognosis, high number of physical subscale indicators), and high-risk (unfavorable prognosis, high levels of psychosocial subscale indicators) categories. The PPST showed adequate sensitivity and specificity; only 2-7% of patients who met reference standard case status (i.e., clinically significant or elevated levels) for disability and emotional distress at 4-month follow-up were classified as low risk at baseline, while 71-79% of patients who met reference standard case status at follow-up were correctly classified as high risk at baseline.
Although the PPST has shown promising initial results in a primarily musculoskeletal pain sample (Simons et al., 2015) , only 6% of the patients in that sample met criteria for primary headache. Given the prevalence of headache in youth and implications for long-term functioning, it is important to now examine the PPST's utility in a large sample of youth with primary headache or if a headache-specific screening tool is indicated. Given that adult studies have indicated that nonspecific baseline factors (pain intensity; pain interference; depression; comorbid pain problems) can predict risk of poor outcome across different pain regions including headache, knee pain, and orofacial pain (Hill et al., 2016; Thomas, Dunn, Mallen, & Peat, 2008; Von Korff & Dunn, 2008; Von Korff & Miglioretti, 2005) , the PPST may also be usefully applied to diverse pediatric pain populations. There is a clear benefit of using a single tool to identify risk in pediatric patients with a variety of primary pain complaints in terms of ease of implementation in busy clinical practice rather than relying on different measures for each population.
In this study, we used the PPST in a large sample of youth who presented at a tertiary care pediatric headache clinic. We expected that the PPST total score and psychosocial subscale would adequately discriminate between reference standard cases and noncases for headache-related variables at baseline (disability, anxiety, depression, fear of pain, and pain catastrophizing) and at follow-up (disability only). Given that the "high-risk" classification is driven by psychosocial factors, we also examined whether receiver operating characteristic (ROC) curve-derived cutoff score for the PPST psychosocial subscale was comparable with the cutoff score derived from the original PPST validation sample (Simons et al., 2015) . Using confirmed cutoff criteria, we expected that patients classified as high risk at baseline would have the worst scores on painrelated variables at baseline and at 2-month followup, whereas patients classified as low risk would have the lowest scores on pain-related variables at baseline and follow-up. For the 2-month follow-up, 49.2% (N ¼ 119) of patients returned for an appointment with the pediatric neurologist at the PHP (M ¼ 1.96 months, SD ¼ 1.66) and completed the functional disability inventory (FDI). There were no significant differences for PPST scores, functional disability, general anxiety, depression, fear of pain, or pain catastrophizing scores at baseline for those who completed the 2-month follow-up and those who did not.
Methods

Participants and Procedure
Measures
Pediatric Pain Screening Tool
The PPST (Simons et al., 2015 ) is a self-report pediatric adaptation of the nine-item Keele SBST (Hill et al., 2008) , comprising two subscales: physical and psychosocial. PPST items refer to participant experiences in the past 2 weeks, with total score ranging from 0 to 9. For items one to eight, participants check "yes" or "no," with "yes" coded as 1. For Item 9, patients check boxes with the following ratings: "not at all," "a little," "some" (all scored as 0), "a lot," "a whole lot" (all scored as 1). Scores for the psychosocial subscale range from 0 to 5, and scores for the physical subscale range from 0 to 4.
Functional Disability
The FDI (Walker & Greene, 1991 ) is a 15-item selfreport measure that assesses perceived difficulty in performing common activities. Higher total scores indicate greater disability. Cronbach's alpha for the baseline data in this sample was .93.
General Anxiety Symptoms
The Revised Children's Manifest Anxiety Scale, second edition (RCMAS-2) (Reynolds & Richmond, 2008 ) is a 49-item self-report measure that assesses anxiety symptoms. Higher total scores indicate greater anxiety symptom severity. Cronbach's alpha in this sample was .93.
Depressive Symptoms
The Children's Depression Inventory (CDI-2) (Kovacs, 1985 ) is a 28-item self-report measure assessing depressive symptoms. Higher total scores indicate greater depressive symptom severity. Cronbach's alpha in this sample was .90.
Fear of Pain
The Fear of Pain Questionnaire, child report (FOPQ-C) (Simons, Sieberg, Carpino, Logan, & Berde, 2011 ) is a 24-item self-report measure that assesses painrelated fear and avoidance. Higher total scores indicate greater fears and avoidance behavior. Cronbach's alpha in this sample was .94.
Pain Catastrophizing
The Pain Catastrophizing Scale for Children (PCS-C) (Crombez et al., 2003 ) is a 13-item self-report measure that assesses rumination, magnification, and perceived helplessness regarding pain. Higher total scores reflect greater catastrophizing. Cronbach's alpha in this sample was .92.
Statistical Analyses
Data were analyzed using SPSS version 22.0 (SPSS IBM, New York, NY). We used ROC curve analysis. ROC curve analysis is generally used to judge a tool's potential usefulness to detect diagnostically or clinically significant levels of disorder or risk in an individual (Youngstrom, 2014) . Usefulness is determined by the tool's ability to be both sensitive and specific to detecting disorder/risk, reported as the area under the curve (AUC) metric. ROC curve analysis can also be used to derive clinically or diagnostically useful cutoff scores from which to allocate patients into a risk group. Meeting "reference standard case status" denotes that patients met criteria for clinically significant or elevated levels of symptoms as determined by preexisting, established cutoffs for each measure.
Discriminant Validity
We used ROC curves to calculate the AUC for the PPST total score and the psychosocial subscale score, comparing scores against "cases" on relevant reference standards. We dichotomized multiitem reference standard measures to generate "cases" and "noncases" using established cutoffs. Reference standard cases were as follows: FDI ! 13 (Kashikar-Zuck et al., 2011), RCMAS-2 ! T-score 60 (Reynolds & Richmond, 2008) , CDI-2 T-score ! 65 (Kovacs, 1985) , FOPQ-C ! 51 (Simons et al., 2011) , and PCS-C ! 26 . We examined PPST total scores and psychosocial subscale scores in relation to functional disability and psychosocial measures at baseline, and PPST total score in relation to functional disability at 2-month follow-up. We additionally identified "psychosocial distress" cases where those patients were cases on two or more of the psychosocial measures. Strength of discrimination criteria was classified according to the following descriptors: <.07 poor discrimination, !0.7 fair discrimination, !0.8 good discrimination, and !0.9 excellent discrimination (Youngstrom, 2014) .
Validating High-Risk Cutoff Scores
The primary purpose of the PPST is to rapidly stratify patients into clinically meaningful subgroups to inform treatment decisions. PPST cutoff scores were previously suggested by Simons and colleagues (Simons et al., 2015) using the primarily musculoskeletal pain sample. Given that the high-risk group classification is driven by psychosocial factors and can be directly tested via ROC curve analysis examining the PPST psychosocial subscale score against reference standard case for psychosocial distress, we compared the current data-indicated cutoff with the established cutoff score.
Concurrent and Predictive Validity
We examined the concurrent and predictive validity of PPST risk groups defined at baseline on disability, anxiety, depression, fear, and catastrophizing at baseline and on disability at 2-month follow-up. We used chi-square and one-way analysis of variances (ANOVAs) to examine differences across the groups based on frequency of reference standard cases and continuous scores at baseline and 2-month follow-up.
Results
PPST Item Endorsement
PPST scores ranged from 0 to 9, thus covering the full possible range (M ¼ 4.5; SD ¼ 2.3). Skew (À.06) and kurtosis (À.73) for total PPST scores were low, indicating a normal distribution. Table I details frequency of endorsement for each item, as well as item endorsement for the original validation paper (Simons et al., 2015) for comparative purposes. For the current sample, "It is difficult for me to be at school all day" (76.9%) was the most frequently endorsed item, whereas "It is not safe for me to be physically active" (80.6%) was the least frequently endorsed item. For the validation sample (Simons et al., 2015) , "Has pain been a problem in the last 2 weeks?" (79.2%) was the most frequently endorsed item, and "I feel that my pain is terrible and it's never going to get any better" (36.6%) was the least frequently endorsed item.
Discriminant Validity
The AUC for the overall PPST score ranged from 0.74 (for disability at follow-up) to 0.88 (for painrelated fear at baseline) (p < .001 for all measures), reflecting fair to good discrimination of cases from noncases (Table II) . The AUC for the PPST psychosocial subscale (five items) was also fair to good (0.71-0.87).
Validating High-Risk Cutoff Scores
We examined the ROC curve for the PPST psychosocial subscale and the psychosocial distress index outcome to validate the high-risk cutoff score (which is driven by psychosocial factors). As can be seen in Figure 1 , a score of !3 was the best concurrent predictor of a reference standard psychosocial distress case, in line with previously established PPST cutoff scores. For this item, patients respond "not at all," "a little," "some," "a lot," and "a whole lot." Responses of "a lot" and "a whole lot" are in the Agree column and coded as endorsement of bothersomeness for the total scale.
We thus used these established criteria for subsequent analyses. Cutoff criteria are as follows: the low-risk group is defined as a PPST total score of 0-2; the medium-risk group is defined as a PPST total score !3, and psychosocial subscale score of 0-2; the high-risk group is defined as a psychosocial subscale score !3. Regarding risk classification for the current sample, 21% were classified as low risk, 31% were classified as medium risk, and 48% were classified as high risk.
Concurrent and Predictive Validity
At baseline, a small percentage (1-6%) of those meeting reference standard case status for high/clinically significant disability, fear of pain, pain catastrophizing, depression, or anxiety were classified as low risk. In contrast, a high percentage (64-90%) of those meeting reference standard case status on these measures were classified as high risk. Among the patients who completed the 2-month followup, a small percentage (6%) of those meeting reference standard case status for clinically significant disability at 2-month follow-up were classified as low risk, whereas a much larger percentage (67%) of those meeting reference standard case status for clinically significant disability were classified as high risk. See Table III . Regarding continuous variables, the omnibus ANOVAs were significant for each (Table IV) . Specifically, the high-risk group had significantly higher functional disability, pain catastrophizing, fear of pain, depression, and anxiety scores at baseline compared with the two other risk groups. In addition, the high-risk group had significantly higher functional disability at 2-month follow-up compared with the low-risk group. When including age as a covariate, all findings remained significant (data available on request).
Discussion
This study examined the utility of the PPST to identify factors associated with adverse functional and psychosocial variables in children and adolescents with recurrent headache, and thus to classify risk groups that can rapidly inform treatment decision-making. A brief screening tool that can be easily administered in busy care settings and can be used to inform treatment decision-making across multiple chronic pain diagnoses has the potential to significantly improve current health-care provision, particularly prevention strategies. Given that headache is one of the most prevalent pain problems reported by young people (Perquin et al., 2000) , it is important that screening tools implicated for wider pediatric chronic pain populations are also useful for this clinical group. Overall, the PPST performed well in this population of young people with persistent headache who presented at a tertiary care clinic. Thus, we provide preliminary evidence that the PPST may be a useful tool for efficiently identifying patients who present at tertiary care settings and are at risk of poor outcomes and effectively classifying patients into risk groups that could drive treatment decisions.
Using ROC and AUC analyses, we found that the PPST was able to discriminate reference standard cases of disability, pain catastrophizing, pain-related fear, and depression and anxiety symptoms at baseline. Perhaps not surprisingly, the PPST was more sensitive to pain-related fear compared with general 10.91* Note. Superscripts (a, b, and c) represent group differences using Bonferroni-corrected post hoc comparisons, with different letters signifying statistically significant group differences. *p < .001.
distress factors of depression and anxiety. The PPST was also able to discriminate reference standard cases of disability longitudinally, at 2-month follow-up. Thus, we provide preliminary evidence that the PPST can adequately identify patients with clinically elevated levels across a range of important pain-related variables, and can adequately predict which patients will have poor physical functioning 2 months later. Rapid identification of current and future functioning is a critical first step in developing streamlined programs aimed at preventing negative pain-related outcomes in young people. Given that a "high-risk" classification is driven by the PPST's psychosocial factors, we also examined whether an ROC curve-derived cutoff score for the PPST psychosocial subscale was comparable with the cutoff score derived from the original PPST validation sample (Simons et al., 2015) , and thus whether recommended cutoff scores for a mixed pain sample could also be effectively used in a headache sample. ROC curve analyses demonstrated that a score of !3 on the PPST psychosocial subscale was the most sensitive and specific score for identifying patients with elevated psychosocial distress at baseline, replicating findings from the validation study. Thus, the existing recommended cutoff scores for risk groups can be usefully applied to the current sample, increasing the feasibility of implementing standard instructions for the PPST in busy multidisciplinary clinical practice.
Most importantly, the baseline PPST risk groups robustly predicted a number of psychosocial functioning measures at baseline, as well as physical functioning at baseline and 2 months later. A small percentage (1-6%) of patients who met reference standard case status (e.g., clinically elevated fear of pain) were classified as low risk at baseline, whereas a large percentage (64-90%) of patients who met reference standard case status were classified as high risk. PPST high-risk classification was sensitive in detecting generalized and pain-specific distress. This is consistent with the scoring approach that relies on endorsement of three or more psychosocial items for high-risk classification. What is striking is that this accuracy is accomplished via only five items, compared with the 110 items that comprise the four measures used to define (e.g., depression) case status. These findings certainly warrant considering implementation of the PPST for greater dissemination and preventive screening with additional assessment triggered in the case of high-risk status.
In addition to the robust findings associated with generalized and pain-specific distress, the PPST provided compelling predictive validity for identifying patients with moderate to severe disability. For disability, it is important to not only examine those who are classified as high risk but also use the medium risk category. For patients classified as medium risk, it is theorized to suggest a moderately unfavorable prognosis, with high level of physical subscale indicators, and appropriate for physiotherapy. For this domain, it is important that the smallest proportion of patients are classified as low risk; this was achieved. Only 3% at baseline and 6% at 2-month follow-up reported moderate to severe functional disability. We did observe a small increase in the percentage of high-risk patients reporting moderate to severe functional disability between baseline and follow-up (64-67%). This is likely because of the fact that the most complex patients are more likely to return for additional recommendations or modifications compared with those who swiftly responded to treatment.
One important question that gave impetus for the current study was whether a tool that was primarily developed for pediatric patients with musculoskeletal pain would also be useful in young people with persistent headache. Adult studies have indicated that nonspecific baseline factors (pain intensity; pain interference; depression) can predict risk of poor outcome across different pain regions including headache, knee pain, and orofacial pain (Hill et al., 2016; Thomas et al., 2008; Von Korff & Dunn, 2008; Von Korff & Miglioretti, 2005) , indicating that the PPST may also be usefully applied to diverse pediatric pain populations. Visual inspection of the PPST items indicates that some items may indeed be more relevant for patients with musculoskeletal pain than headache. In particular, the items "I can only walk a short distance because of my pain" (Item 2) and "It's not really safe for me to be physically active" (Item 5) are movementrelated and thus may be more relevant for patients with musculoskeletal pain than those with headache. However, given that Item 5 represents fear of pain, and our results indicate that the PPST is excellent at discriminating those with high levels of fear of pain (90% discrimination), it seems pertinent to retain this item to best predict pain-related distress in young patients with headache. Nonetheless, further studies may investigate the utility of amending the PPST to replace or add more headache-relevant items. Previous work on fear of pain in young people with persistent headache indicates that items regarding cognitive demands and stress (e.g., "I can't think straight when I'm in pain") may be more relevant for this population (Simons, Pielech, Cappucci, & Lebel, 2014) . Practically speaking, the decision to use a tool that is broadly relevant for diverse pediatric pain populations versus a tool that has been designed or amended specifically for a headache population may depend on the clinical setting (chronic pain clinic vs. headache clinic) and the length of the referral appointment visit.
This study has limitations. First, while we had access to data regarding multiple pain-related variables at baseline, we only had access to 2-month follow-up data on disability. This precludes consideration of the PPST in screening prognostic risk for other important psychosocial factors. Relatedly, we also did not report data regarding pain symptomatology, despite that prognosis of continuing pain symptoms is likely a primary concern for patients presenting to a headache clinic. A recent meta-analysis indicated that the SBST and another commonly used screening tool (the Orebro Musculoskeletal Pain Screening Questionnaire; OMPSQ) are poor at discriminating those with low and high pain symptoms . Thus, the predictive validity of the PPST for pain symptomatology is an important and outstanding question and perhaps may not be served by this measure. Second, we recruited patients from a tertiary care setting who had been experiencing pain for varying amounts of time, introducing heterogeneity and prohibiting any conclusions regarding the utility of the PPST in predicting the transition from acute to chronic pain. This tertiary care sample also explains the relatively high proportion of youth that were identified as high risk, and we would indeed expect a lower proportion to be identified from a general population or primary care sample. Relatedly, the adult SBST was originally developed for use in a primary care setting, and recent evidence from adult studies suggests that screening tools may be less effective at predicting risk in secondary/tertiary care settings (Morsø, Kent, Manniche, & Albert, 2014) . Instead, it is suggested that classifying all patients presenting to secondary/tertiary care as "high-risk" may be most appropriate . Although these finds run counter to this argument, it remains to be determined whether the PPST is indeed more effective at classifying headache-related risk in a primary care setting where patients are more likely to report new-onset headache pain that is not yet persistent.
Despite limitations, this study provides important information for risk screening in pediatric pain as this field emerges. Chronic pain is estimated to effect 1.7 million children in the United States alone, costing 19.5 billion dollars per year (Groenewald, Essner, Wright, Fesinmeyer, & Palermo, 2014) . In particular, headache is one of the most commonly reported pain complaints in childhood and adolescence (Perquin et al., 2000) and is associated with significant longterm suffering, even into adulthood. We provide preliminary evidence that the PPST may fill a currently unmet need for providers who see young people with headache in their tertiary practice, as it provides a tool for rapidly (1-2 min) identifying potential risk and, based on this classification, informing treatment decisions. A clear next step is to examine whether stratification of patients into treatment groups, for example, treatments involving reassurance, advice, and education (for low risk); advice and physiotherapy (for medium risk); and combined physical and CBT (for high risk) can improve health-care provision for young people with persistent headaches. Of particular relevance are whether risk-based treatment stratification can result in higher adherence to treatment recommendations, greater health-care savings, and most importantly improved clinical outcomes.
Persistent headache is a common and debilitating pediatric health problem. Prevention strategies are needed to ameliorate short-and long-term suffering. We provide evidence that the PPST can efficiently and effectively identify treatment-modifiable biopsychosocial factors and disability outcomes in youth with persistent headache. The PPST may be a useful tool for informing tertiary prevention strategies. These preliminary results warrant further investigation of the PPST in primary and secondary prevention strategies, particularly in screening for prognostic risk of headache persistence and the emergence of headache-related disability in primary care settings. Further research is also needed to establish whether the PPST can aid clinical decision-making by informing treatment approaches, which are directly targeted to patient needs.
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